Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (HKG: 1349)

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	1,222	1,196	1,289	1,209	1,397	576.8
Short-Term Investments	-	-	30	-	-	-
Cash & Short-Term Investments	1,222	1,196	1,319	1,209	1,397	576.8
Cash Growth	-0.70%	-9.35%	9.13%	-13.46%	142.18%	-1.94%
Accounts Receivable	565.88	620.49	679.12	672.49	583.1	504.6
Other Receivables	0.5	1.34	5.14	1.18	0.91	6.8
Receivables	566.38	621.82	684.26	673.66	584	511.39
Inventory	52.71	43.65	40.53	35.63	36.01	31.87
Other Current Assets	28.04	8.05	25.1	9.77	9.67	18.18
Total Current Assets	1,870	1,869	2,069	1,928	2,027	1,138
Property, Plant & Equipment	504.52	475.33	351.51	301.92	248.77	260.21
Long-Term Investments	279.24	287.53	306.37	327.86	66.71	28.08
Other Intangible Assets	79.57	86.35	62.32	88.46	56.18	60.46
Long-Term Deferred Tax Assets	99.4	100.87	85.9	79.22	62.97	58.18
Long-Term Deferred Charges	8.36	11.32	43.09	36.12	32.53	17.39
Other Long-Term Assets	8	45.85	57.62	19.64	6.97	2.27
Total Assets	2,849	2,877	2,976	2,781	2,501	1,565
Accounts Payable	13.87	8.05	7.43	8.17	5.27	6.83
Accrued Expenses	277.2	36.86	34.67	53.78	48.73	320.69
Short-Term Debt	-	-	101	-	-	148.94
Current Portion of Leases	3.24	6.33	8.22	8.68	6.09	4.03
Current Income Taxes Payable	-	1.61	1.63	10.4	4.6	18.65
Current Unearned Revenue	0.48	334.45	412.77	348.87	297.01	2.04
Other Current Liabilities	186.51	117.72	107.63	98.3	66.22	70.17
Total Current Liabilities	481.3	505.02	673.34	528.2	427.93	571.35
Long-Term Leases	8.98	10.95	15.6	22.59	13.6	2.12
Long-Term Unearned Revenue	0.99	2.15	34.04	40.8	50.69	58.21
Total Liabilities	491.27	518.12	722.99	591.58	492.21	631.68
Common Stock	103.66	103.66	102.9	104.3	104.3	92.3
Additional Paid-In Capital	1,290	1,289	1,225	1,265	1,200	237.8
Retained Earnings	968.37	970.46	934.39	868.43	707.28	615.38
Treasury Stock	-	-	-	-40.82	-	-
Comprensive Income & Other	-5.72	-5.86	-5.2	-4.05	-0.77	-13.95
Total Common Equity	2,357	2,358	2,257	2,193	2,011	931.53
Minority Interest	0.88	1.01	-4.08	-3.36	-2.44	1.62
Shareholders' Equity	2,357	2,359	2,253	2,190	2,008	933.15
Total Liabilities & Equity	2,849	2,877	2,976	2,781	2,501	1,565
Total Debt	12.22	17.28	124.81	31.26	19.69	155.1
Net Cash (Debt)	1,210	1,179	1,194	1,178	1,377	421.7
Net Cash Growth	8.85%	-1.33%	1.43%	-14.49%	226.58%	-3.77%
Net Cash Per Share	1.17	1.14	1.16	1.13	1.39	0.46
Filing Date Shares Outstanding	1,037	1,037	1,029	1,032	1,043	923
Total Common Shares Outstanding	1,037	1,037	1,029	1,032	1,043	923
Working Capital	1,388	1,364	1,396	1,400	1,599	566.89
Book Value Per Share	2.27	2.27	2.19	2.12	1.93	1.01
Tangible Book Value	2,277	2,271	2,195	2,104	1,955	871.07
Tangible Book Value Per Share	2.20	2.19	2.13	2.04	1.87	0.94
Buildings	369.46	199.22	198.52	198.52	197.33	204.68
Machinery	498.09	388.63	341.74	322.86	292.69	277.42
Construction In Progress	0.19	229.96	122.37	48.9	1.83	0.33

Source: S&P Capital IQ. Standard template. Financial Sources.